Lv1
46 积分 2023-12-05 加入
IRF4 maintenance in multiple myeloma is conserved in de novo-derived inobrodib resistance, conferring cross resistance to immunomodulatory drugs
13天前
已完结
IRF4 maintenance in multiple myeloma is conserved in de novo-derived inobrodib resistance, conferring cross resistance to immunomodulatory drugs
23天前
已完结
The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells
3个月前
已完结
IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK
4个月前
已完结
Loss of IRF4 Results in Multiple Myeloma Cell Apoptosis through the Transcriptional up-Regulation of the BH3-Only Proteins Bmf and BIM
4个月前
已完结
Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma
4个月前
已完结
Loss of BCL7A permits IRF4 transcriptional activity and cellular growth in multiple myeloma
4个月前
已完结
IRF4 Is Reciprocally Dysregulated Via NF-Κb-Dependent Expression and Loss-of-Function Mutations in Multiple Myeloma
7个月前
已关闭
Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies
9个月前
已完结
Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies
9个月前
已完结
皖公网安备34019202002308
